{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-006448","form_type":"8-K","ticker":"IXHL","cik":"0001873875","company_name":"Incannex Healthcare Inc.","filed_at":"2026-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.634665+00:00","generated_at":"2026-05-16T08:56:13.518901+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Incannex Healthcare forms Clinical Advisory Board for PSX-001 anxiety program","bullets":["Clinical Advisory Board (CAB) established to support PSX-001 development for generalized anxiety disorder.","CAB will advise on trial design, endpoint selection, regulatory engagement, and strategic approach.","Inaugural members: Dr. C. Neill Epperson, Dr. Charles B. Nemeroff, and Dr. Alan F. Schatzberg.","CMO Dr. Lou Barbato says CAB will help inform key development decisions and support shareholder value."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-006448","json":"https://secwatch.observer/filing/0001213900-26-006448.json","markdown":"https://secwatch.observer/filing/0001213900-26-006448.md","text":"https://secwatch.observer/filing/0001213900-26-006448.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026006448/0001213900-26-006448-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026006448/ea0273695-8k_incannex.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T08:56:13.518901+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}